相关实验视频

Updated: May 1, 2026

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
06:38

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Published on: November 8, 2011

40.6K

移植后的Epstein-Barr病毒相关淋巴增殖性疾病中的表单:患者和瘤学家的观点

Antonio Perez-Martinez1,2,3, Anarbella Lastra Rodrigo4, Esther Ramos Boluda5

  • 1Pediatric Hemato-Oncology Department, La Paz University Hospital, Universidad Autónoma de Madrid, Paseo de la Castellana 261, 28046, Madrid, Spain. aperezmartinez@salud.madrid.org.

Advances in therapy
|May 30, 2025
PubMed
概括

塔贝莱克卢塞尔为治疗与爱斯坦-巴尔病毒相关的移植后淋巴增殖性疾病 (EBV+ PTLD) 提供了新的希望. 这种新疗法成功地扭转了一个年轻患者的严重,以前无法治疗的病例.

关键词:
爱斯坦-巴尔病毒患者的观点患者的观点.移植后的淋巴增殖性疾病这是一张表格cleucel.

更多相关视频

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

9.3K
Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

4.1K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K